Skip to content
News
Precision Medicine May Be Health Care’s Next Big Thing, But We Don’t Yet Know How to Evaluate Precision Drugs
November 9, 2016/
Finally, there’s a drug available to treat Duchenne muscular dystrophy, a rare, fatal genetic muscle-wasting disease that grips roughly 10,000 people, mostly boys, in the U.S., who are unlikely to live into their 30s and typically lose the ability to walk in adolescence.
